The American Intellectual Property Law Association (AIPLA) will be offering a webinar on "Biosimilars: Regulation, Litigation and New Developments Patent Practitioners and Regulatory Attorneys Should Know" on August 27, 2015 from 12:30 - 2:00 pm (Eastern). Debora Plehn-Dujowich of Prismatic Law Group, PLLC, James C. Shehan of Hyman Phelps & McNamara, and Sanya Sukduang of Finnegan Henderson Farabow Garrett & Dunner, LLP will review the FDA regulatory pathway for biosimilars in the U.S. and how biosimilar applicants may use data obtained abroad in certain cases. Issues surrounding litigation for biosimilars will also be covered, such as whether the "patent dance" is optional, and whether other routes such as PTAB trials should be pursued. Recent developments in biosimilar applications in the U.S. and abroad will also be reviewed, as well as the new Guidance documents published by the FDA.
The registration fee for the program is $95 (AIPLA member rate) or $150 (non-member rate). Those interested in registering for the program, can do so here.
Comments